Clinical Trial: Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07203352) titled 'Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL' on Sept. 23.

Brief Summary: This prospective, randomized, controlled trial evaluates the efficacy and safety of a new targeted drug combined with chemotherapy versus standard chemotherapy alone. Eligible patients were randomized 1:1 to either the treatment or control group.

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Acute Lymphoblastic Leukemia

Intervention: DRUG: targeted drug

Patients randomly assigned to the control group will receive standard chemotherapy treatment, but they cannot use targeted drugs in combination.The sub...